Literature DB >> 16534566

Enhanced clinical utility of the NucliSens EasyQ RSV A+B Assay for rapid detection of respiratory syncytial virus in clinical samples.

C Moore1, M Valappil, S Corden, D Westmoreland.   

Abstract

The aim of the present study was to compare traditional methods for the detection of respiratory syncytial virus with a newly developed commercial assay based on real-time nucleic acid sequence based amplification. Respiratory syncytial virus is a major cause of severe respiratory infection in infants and in certain groups of older children and adults. Treatment options are limited, but a rapid diagnosis improves patient management and infection control. The rapid diagnosis of respiratory syncytial virus currently relies on antigen detection assays. These tests are limited to use in certain good-quality types of samples, which are rarely obtained from adult patients. Molecular-based assays for the detection of respiratory syncytial virus are shown to be highly sensitive, specific, and more rapid than cell culture techniques. This retrospective study compared traditional laboratory techniques for the detection of respiratory syncytial virus in 508 respiratory samples collected during the winter months of 2003-2004 against the recently developed, commercially available NucliSens EasyQ Respiratory Syncytial Virus A+B assay (bioMérieux, Marcy l'Etoile, France), which is based on real-time nucleic acid sequence based amplification using molecular beacons and an internal control. Using traditional techniques, the prevalence of respiratory syncytial virus in the samples tested was found to be 21%. Using the real-time nucleic acid sequence-based amplification assay, an additional 41 samples from patients with a clinically diagnosed respiratory illness were found to be positive for respiratory syncytial virus. The NucliSens EasyQ assay was shown to be sensitive and specific for the detection of respiratory syncytial virus A+B in different types of respiratory samples. Moreover, the time required to complete the assay was <4 h, so results could be obtained on the same day as sample receipt in the laboratory.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16534566     DOI: 10.1007/S10096-006-0112-4

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  25 in total

1.  Stable and noncompetitive RNA internal control for routine clinical diagnostic reverse transcription-PCR.

Authors:  Kate E Dingle; Derrick Crook; Katie Jeffery
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

2.  Rapid and simple method for purification of nucleic acids.

Authors:  R Boom; C J Sol; M M Salimans; C L Jansen; P M Wertheim-van Dillen; J van der Noordaa
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

3.  Improved confidence intervals for the difference between binomial proportions based on paired data.

Authors:  R G Newcombe
Journal:  Stat Med       Date:  1998-11-30       Impact factor: 2.373

Review 4.  Respiratory syncytial virus genetic and antigenic diversity.

Authors:  W M Sullender
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

5.  Diagnosis of respiratory syncytial virus infection: comparison of reverse transcription-PCR to viral culture and serology in adults with respiratory illness.

Authors:  Ann R Falsey; Maria A Formica; Edward E Walsh
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

Review 6.  Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment.

Authors:  J B Domachowske; H F Rosenberg
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

Review 7.  Advances in the laboratory diagnosis of viral respiratory disease.

Authors:  Kelly J Henrickson
Journal:  Pediatr Infect Dis J       Date:  2004-01       Impact factor: 2.129

8.  Rapid detection of respiratory syncytial virus in nasopharyngeal aspirates by reverse transcription and polymerase chain reaction amplification.

Authors:  A W Paton; J C Paton; A J Lawrence; P N Goldwater; R J Harris
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

9.  Simultaneous detection, subgrouping, and quantitation of respiratory syncytial virus A and B by real-time PCR.

Authors:  Aizhong Hu; Melissa Colella; John S Tam; Ruth Rappaport; Sheau-Mei Cheng
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

Review 10.  Prophylaxis, therapy and prevention of viral respiratory infections.

Authors:  Dimitris A Kafetzis
Journal:  Paediatr Respir Rev       Date:  2004       Impact factor: 2.726

View more
  11 in total

1.  Development of a sensitive loop-mediated isothermal amplification assay that provides specimen-to-result diagnosis of respiratory syncytial virus infection in 30 minutes.

Authors:  James Mahony; Sylvia Chong; David Bulir; Alexandra Ruyter; Ken Mwawasi; Daniel Waltho
Journal:  J Clin Microbiol       Date:  2013-06-12       Impact factor: 5.948

Review 2.  Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients.

Authors:  S Samuel Weigt; Aric L Gregson; Jane C Deng; Joseph P Lynch; John A Belperio
Journal:  Semin Respir Crit Care Med       Date:  2011-08-19       Impact factor: 3.119

3.  Comparison of Cepheid's analyte-specific reagents with BD directigen for detection of respiratory syncytial virus.

Authors:  Jennifer S Goodrich; Melissa B Miller
Journal:  J Clin Microbiol       Date:  2006-12-20       Impact factor: 5.948

Review 4.  Detection of respiratory viruses by molecular methods.

Authors:  James B Mahony
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

5.  Clinical evaluation of NucliSENS magnetic extraction and NucliSENS analyte-specific reagents for real-time detection of human metapneumovirus in pediatric respiratory specimens.

Authors:  Christine C Ginocchio; Ryhana Manji; Madhavi Lotlikar; Fan Zhang
Journal:  J Clin Microbiol       Date:  2008-02-13       Impact factor: 5.948

6.  Diagnosis of respiratory syncytial virus infection.

Authors:  Therese Popow-Kraupp; Judith H Aberle
Journal:  Open Microbiol J       Date:  2011-12-30

7.  Sensitive commercial NASBA assay for the detection of respiratory syncytial virus in clinical specimen.

Authors:  Ramona Liza Tillmann; Arne Simon; Andreas Müller; Oliver Schildgen
Journal:  PLoS One       Date:  2007-12-26       Impact factor: 3.240

Review 8.  Nucleic acid amplification tests for detection of respiratory viruses.

Authors:  Julie D Fox
Journal:  J Clin Virol       Date:  2007-11       Impact factor: 3.168

9.  Enhanced identification of viral and atypical bacterial pathogens in lower respiratory tract samples with nucleic acid amplification tests.

Authors:  Bonita E Lee; Joan L Robinson; Vinod Khurana; Xiaoli L Pang; Jutta K Preiksaitis; Julie D Fox
Journal:  J Med Virol       Date:  2006-05       Impact factor: 2.327

Review 10.  Community-acquired viral pneumonia.

Authors:  Ann R Falsey
Journal:  Clin Geriatr Med       Date:  2007-08       Impact factor: 3.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.